Moes, Harmen R.
Henriksen, Tove
Sławek, Jarosław
Phokaewvarangkul, Onanong
Buskens, Erik
van Laar, Teus http://orcid.org/0000-0001-5088-480X
Article History
Received: 28 February 2023
Accepted: 16 May 2023
First Online: 27 July 2023
Conflict of interest
: HRM received a PhD research grant from the University Medical Center Groningen, Junior Scientific Masterclass [grant number GR-AGIKO 18–02]. This PhD project includes the development and validation of the Dutch DAT Screening tool (D-DATS). He declares no financial interests related to this work. TH has no conflict of interests relevant to this work. She reports having received honorary for talks for AbbVie, Britannia, Nordic Infucare, Ipsen, Convatec, and NeuroDerm. In addition, she is PI at a study funded by AbbVie, and a DMC board member at a study funded by Lundbeck. JS has no disclosures to report regarding this contribution. He has given lectures and served on advisory boards for AbbVie and Ever Pharma. OP has no competing interests to declare relevant to the content of this article. EB has no disclosures to report regarding this contribution. He received funding from Dutch Heart Foundation matched by an unrestricted grant from Stryker through national industry platform in the domain of acute stroke. He participated as chair and committee member on several prevention programs from National Health Care research program ZonMw. TvL has no nothing to disclose which is directly or indirectly related to the work submitted for publication. He has received consulting fees from AbbVie, Britannia Pharm., Eurocept, and Clexio, and research grants from the Michael J. Fox Foundation, the Dutch Brain Foundation, and the University Medical Center Groningen.